| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clin Mol Hepatol.2017;23(4):308-310.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0109
                                 Cited By 2
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol.2017;23(4):302-307.   Published online December 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0078
                                 Cited By 8
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Dong Ho Lee
Clin Mol Hepatol.2017;23(4):290-301.   Published online October 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0042
                                 Cited By 7
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin
Clin Mol Hepatol.2017;23(4):280-289.   Published online September 15, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0037
                                 Cited By 10
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol.2017;23(4):273-279.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0108
                                 Cited By 5
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 9
A case of Alagille syndrome presenting with chronic cholestasis in an adult
Jihye Kim, Bumhee Yang, Namyoung Paik, Yon Ho Choe, Yong-Han Paik
Clin Mol Hepatol.2017;23(3):260-264.   Published online July 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0057
                                 Cited By 1
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals
Yvelise Ferro, Ilaria Carè, Elisa Mazza, Francesco Provenzano, Carmela Colica, Carlo Torti, Stefano Romeo, Arturo Pujia, Tiziana Montalcini
Clin Mol Hepatol.2017;23(3):249-259.   Published online July 28, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0019
                                 Cited By 2
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai
Clin Mol Hepatol.2017;23(3):239-248.   Published online July 14, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0008
                                 Cited By 4
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.2017;23(3):230-238.   Published online June 30, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0003
                                 Cited By 4
Influence of ultrasound contrast agents on spectral Doppler analysis in recipients of liver transplantation
Young Seo Cho, Kyoung Won Kim, Hye Young Jang, Bo Hyun Kim, Jeongjin Lee, Gi Won Song, Sung Gyu Lee, Dagvasumberel Munkhbaatar
Clin Mol Hepatol.2017;23(3):224-229.   Published online July 4, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0064
                              
Surveillance of hepatocellular carcinoma: is only ultrasound enough?
Woo Kyoung Jeong
Clin Mol Hepatol.2017;23(3):222-223.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0046
                              
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(3):219-221.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0045
                              
Current status of and strategies for hepatitis C control in South Korea
Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim
Clin Mol Hepatol.2017;23(3):212-218.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0105
                                 Cited By 4
Current status and strategies for hepatitis B control in Korea
Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim
Clin Mol Hepatol.2017;23(3):205-211.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0104
                                 Cited By 12
Current status and strategies for the control of viral hepatitis A in Korea
Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim
Clin Mol Hepatol.2017;23(3):196-204.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0034
                                 Cited By 3
Current status and strategies for viral hepatitis control in Korea
Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(3):189-195.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0033
                                 Cited By 2
Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy
Wonyong Jo, Young-Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Jeongmin Hong, Sang Su Lee, Ji Eun Kim, Gyung Hyuck Ko, Hyun-Ok Kim
Clin Mol Hepatol.2017;23(2):184-187.   Published online May 8, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0035
                                 Cited By 1
A case of ruptured hepatic angiomyolipoma in a young male
Sun Hwa Kim, Tae Wook Kang, Kyunghee Lim, Hyun Sung Joh, Jiseok Kang, Dong Hyun Sinn
Clin Mol Hepatol.2017;23(2):179-183.   Published online April 28, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0027
                              
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary         Cited By 5
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2017;23(2):160-169.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0088
                                 Cited By 3
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2017;23(2):154-159.   Published online May 8, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0067
                                 Cited By 2
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol.2017;23(2):147-153.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0055
                                 Cited By 2
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Mingkuan Su, Jianfeng Guo, Jiancheng Huang
Clin Mol Hepatol.2017;23(2):138-146.   Published online April 21, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0083
                                 Cited By 2
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2017;23(2):128-137.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0071
                              Supplementary         Cited By 8
Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
Nae-Yun Heo
Clin Mol Hepatol.2017;23(2):125-127.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0106
                                 Cited By 1
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clin Mol Hepatol.2017;23(2):123-124.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0107
                              
Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
Dong Joon Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(2):115-122.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0018
                                 Cited By 4
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                                 Cited By 10
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol.2017;23(2):103-108.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0103
                                 Cited By 8
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 571
TOTAL : 113463